Patient-derived Xenograft (PDX) Modeling of Treatment Response for Triple Negative Breast Cancer

NCT02247037 · clinicaltrials.gov ↗

COMPLETED

Status

68

Enrollment

OTHER

Sponsor class

Conditions

Triple Negative Breast Cancer

Interventions

OTHER: Chemotherapy

Sponsor

Icahn School of Medicine at Mount Sinai

Collaborators

[object Object]